The Pathogenesis and Immunobiology of Mousepox

Advances in Immunology

Volumn 129, Issue , 2016, Pages 251-276

  Sigal, Luis J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Adaptive immunity; Antibodies; CD4 T lymphocytes; CD8 T lymphocytes; Ectromelia virus; Innate immunity; Interferon; Mousepox; Natural killer cells; Orthopoxvirus; Poxvirus; Viral immunity; Viral pathogenesis

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD40 LIGAND MONOCLONAL ANTIBODY; GRANZYME A; GRANZYME B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; MODIFIED VACCINIA VIRUS ANKARA 5T4 VACCINE; MYELOID DIFFERENTIATION FACTOR 88; STAT1 PROTEIN; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR STING; UNCLASSIFIED DRUG; VIRAL PROTEIN;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COWPOX VIRUS; ECTROMELIA VIRUS; GENE DELETION; HUMAN; IMMUNIZATION; IMMUNOBIOLOGY; IN VIVO STUDY; INNATE IMMUNITY; KLRD1 GENE; MOUSEPOX; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RMP1 GENE; SIGNAL TRANSDUCTION; SMALLPOX VIRUS; VACCINIA VIRUS; VIRUS GENE; VIRUS RESISTANCE; ANIMAL; C57BL MOUSE; DISEASE MODEL; DISEASE RESISTANCE; ECTROMELIA, INFECTIOUS; IMMUNOLOGY; MOUSE; PATHOGENICITY; SMALLPOX; VACCINATION; VIROLOGY; VIRULENCE;

ADAPTIVE IMMUNITY; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE RESISTANCE; ECTROMELIA VIRUS; ECTROMELIA, INFECTIOUS; HUMANS; MICE; MICE, INBRED C57BL; SMALLPOX; VACCINATION; VACCINIA VIRUS; VIRAL PROTEINS; VIRULENCE;

EID: 84947571742     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/bs.ai.2015.10.001     Document Type: Chapter

References (134)

1. Ahmed, R., Gray, D., Immunological memory and protective immunity: Understanding their relation. Science, 272, 1996, 54.
2. Alcami, A., Viral mimicry of cytokines, chemokines and their receptors. Nature Reviews. Immunology, 3, 2003, 36.
3. Amanna, I.J., Slifka, M.K., Wanted, dead or alive: New viral vaccines. Antiviral Research, 84, 2009, 119.
4. Appleyard, G., Andrews, C., Neutralizing activities of antisera to poxvirus soluble antigens. The Journal of General Virology, 23, 1974, 197.
5. Appleyard, G., Hapel, A.J., Boulter, E.A., An antigenic difference between intracellular and extracellular rabbitpox virus. The Journal of General Virology, 13, 1971, 9.
6. Bachmann, M.F., Hunziker, L., Zinkernagel, R.M., Storni, T., Kopf, M., Maintenance of memory CTL responses by T helper cells and CD40-CD40 ligand: Antibodies provide the key. European Journal of Immunology, 34, 2004, 317.
7. Benhnia, M.R., McCausland, M.M., Laudenslager, J., Granger, S.W., Rickert, S., Koriazova, L., et al. Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5. Journal of Virology, 83, 2009, 12355.
8. Billings, P., Burakoff, S., Dorf, M.E., Benacerraf, B., Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2 K or D gene products. The Journal of Experimental Medicine, 145, 1977, 1387.
9. Biron, C.A., Byron, K.S., Sullivan, J.L., Severe herpesvirus infections in an adolescent without natural killer cells. The New England Journal of Medicine, 320, 1989, 1731.
10. Biron, C.A., Nguyen, K.B., Pien, G.C., Cousens, L.P., Salazar-Mather, T.P., Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annual Review of Immunology, 17, 1999, 189.
11. Blanden, R.V., Mechanisms of recovery from a generalized viral infection: Mousepox. I. The effects of anti-thymocyte serum. The Journal of Experimental Medicine, 132, 1970, 1035.
12. Blanden, R.V., Mechanisms of recovery from a generalized viral infection: Mousepox. 3. Regression infectious foci. The Journal of Experimental Medicine, 133, 1971, 1090.
13. Blanden, R.V., Mechanisms of recovery from a generalized viral infection: Mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells. The Journal of Experimental Medicine, 133, 1971, 1074.
14. Blanden, R.V., Doherty, P.C., Dunlop, M.B., Gardner, I.D., Zinkernagel, R.M., David, C.S., Genes required for cytotoxicity against virus-infected target cells in K and D regions of H-2 complex. Nature, 254, 1975, 269.
15. Blasco, R., Moss, B., Role of cell-associated enveloped vaccinia virus in cell-to-cell spread. Journal of Virology, 66, 1992, 4170.
16. Boulter, E.A., Appleyard, G., Differences between extracellular and intracellular forms of poxvirus and their implications. Progress in Medical Virology, 16, 1973, 86.
17. Brown, D.M., Dilzer, A.M., Meents, D.L., Swain, S.L., CD4 T cell-mediated protection from lethal influenza: Perforin and antibody-mediated mechanisms give a one-two punch. Journal of Immunology, 177, 2006, 2888.
18. Brownstein, D.G., Bhatt, P.N., Gras, L., Budris, T., Serial backcross analysis of genetic resistance to mousepox, using marker loci for Rmp-2 and Rmp-3. Journal of Virology, 66, 1992, 7073.
19. Brownstein, D.G., Bhatt, P.N., Gras, L., Jacoby, R.O., Chromosomal locations and gonadal dependence of genes that mediate resistance to ectromelia (mousepox) virus-induced mortality. Journal of Virology, 65, 1991, 1946.
20. Brownstein, D.G., Gras, L., Chromosome mapping of Rmp-4, a gonad-dependent gene encoding host resistance to mousepox. Journal of Virology, 69, 1995, 6958.
21. Bukowski, J.F., Woda, B.A., Welsh, R.M., Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. Journal of Virology, 52, 1984, 119.
22. Buller, R.M., Holmes, K.L., Hugin, A., Frederickson, T.N., Morse, H.C. 3rd, Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature, 328, 1987, 77.
23. Burnet, F.M., Boake, W.C., The relationship between the virus of infectious ectromelia of mice and vaccinia virus. Journal of Immunology, 53, 1946, 1.
24. Burton, D.R., Antibodies, viruses and vaccines. Nature Reviews. Immunology, 2, 2002, 706.
25. Chaudhri, G., Panchanathan, V., Bluethmann, H., Karupiah, G., Obligatory requirement for antibody in recovery from a primary poxvirus infection. Journal of Virology, 80, 2006, 6339.
26. Chaudhri, G., Panchanathan, V., Buller, R.M., van den Eertwegh, A.J., Claassen, E., Zhou, J., et al. Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox. Proceedings of the National Academy of Sciences of the United States of America, 101, 2004, 9057.
27. Delano, M.L., Brownstein, D.G., Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype. Journal of Virology, 69, 1995, 5875.
28. Eidenschenk, C., Jouanguy, E., Alcais, A., Mention, J.J., Pasquier, B., Fleckenstein, I.M., et al. Familial NK cell deficiency associated with impaired IL-2- and IL-15-dependent survival of lymphocytes. Journal of Immunology, 177, 2006, 8835.
29. Epperson, M.L., Lee, C.A., Fremont, D.H., Subversion of cytokine networks by virally encoded decoy receptors. Immunological Reviews, 250, 2012, 199.
30. Etzioni, A., Eidenschenk, C., Katz, R., Beck, R., Casanova, J.L., Pollack, S., Fatal varicella associated with selective natural killer cell deficiency. The Journal of Pediatrics, 146, 2005, 423.
31. Fang, M., Cheng, H., Dai, Z., Bu, Z., Sigal, L.J., Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host. Virology, 345, 2006, 231.
32. Fang, M., Lanier, L.L., Sigal, L.J., A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathogens, 4, 2008, e30.
33. Fang, M., Orr, M.T., Spee, P., Egebjerg, T., Lanier, L.L., Sigal, L.J., CD94 is essential for NK cell-mediated resistance to a lethal viral disease. Immunity, 34, 2011, 579.
34. Fang, M., Remakus, S., Roscoe, F., Ma, X., Sigal, L.J., CD4 + T cell help is dispensable for protective CD8 + T cell memory against mousepox virus following vaccinia virus immunization. Journal of Virology, 89, 2015, 776.
35. Fang, M., Roscoe, F., Sigal, L.J., Age-dependent susceptibility to a viral disease due to decreased natural killer cell numbers and trafficking. The Journal of Experimental Medicine, 207, 2010, 2369.
36. Fang, M., Siciliano, N.A., Hersperger, A.R., Roscoe, F., Hu, A., Ma, X., et al. Perforin-dependent CD4 + T-cell cytotoxicity contributes to control a murine poxvirus infection. Proceedings of the National Academy of Sciences of the United States of America, 109, 2012, 9983.
37. Fang, M., Sigal, L.J., Antibodies and CD8 + T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus. Journal of Immunology, 175, 2005, 6829.
38. Fang, M., Sigal, L.J., Direct CD28 costimulation is required for CD8 + T cell-mediated resistance to an acute viral disease in a natural host. Journal of Immunology, 177, 2006, 8027.
39. Fenner, F., Studies in infectious ectromelia in mice; natural transmission; the portal of entry of the virus. The Australian Journal of Experimental Biology and Medical Science, 25, 1947, 275.
40. Fenner, F., Studies in infectious ectromelia of mice; immunization of mice against ectromelia with living vaccinia virus. The Australian Journal of Experimental Biology and Medical Science, 25, 1947, 257.
41. Fenner, F., The epizootic behaviour of mouse-pox, infectious ectromelia. British Journal of Experimental Pathology, 29, 1948, 69.
42. Fenner, F., The pathogenesis of the acute exanthems; an interpretation based on experimental investigations with mousepox; infectious ectromelia of mice. Lancet, 2, 1948, 915.
43. Fenner, F., Mouse-pox; infectious ectromelia of mice; a review. Journal of Immunology, 63, 1949, 341.
44. Fenner, F., Studies in mousepox, infectious ectromelia of mice; quantitative investigations on the spread of virus through the host in actively and passively immunized animals. The Australian Journal of Experimental Biology and Medical Science, 27, 1949, 1.
45. Fenner, F., Smallpox and its eradication. 1988, World Health Organization, Geneva.
46. Fields, B.N., Knipe, D.M., Howley, P.M., Fields virology. 5th ed., 2007, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia.
47. Flint, S.J., American Society for Microbiology, Principles of virology. 3rd ed., 2009, ASM Press, Washington, DC.
48. Fogg, C., Lustig, S., Whitbeck, J.C., Eisenberg, R.J., Cohen, G.H., Moss, B., Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions. Journal of Virology, 78, 2004, 10230.
49. French, A.R., Yokoyama, W.M., Natural killer cells and viral infections. Current Opinion in Immunology, 15, 2003, 45.
50. Galmiche, M.C., Goenaga, J., Wittek, R., Rindisbacher, L., Neutralizing and protective antibodies directed against vaccinia virus envelope antigens. Virology, 254, 1999, 71.
51. Holechek, S.A., Denzler, K.L., Heck, M.C., Schriewer, J., Buller, R.M., Legrand, F.A., et al. Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia viruses. PLoS One, 8, 2013, e77879.
52. Honda, K., Yanai, H., Takaoka, A., Taniguchi, T., Regulation of the type I IFN induction: A current view. International Immunology, 17, 2005, 1367.
53. Iakoubova, O.A., Olsson, C.L., Dains, K.M., Ross, D.A., Andalibi, A., Lau, K., et al. Genome-tagged mice (GTM): Two sets of genome-wide congenic strains. Genomics, 74, 2001, 89.
54. Israely, T., Melamed, S., Achdout, H., Erez, N., Politi, B., Waner, T., et al. TLR3 and TLR9 agonists improve postexposure vaccination efficacy of live smallpox vaccines. PLoS One, 9, 2014, e110545.
55. Iwasaki, A., Medzhitov, R., Regulation of adaptive immunity by the innate immune system. Science, 327, 2010, 291.
56. Jacoby, R.O., Bhatt, P.N., Brownstein, D.G., Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus. Archives of Virology, 108, 1989, 49.
57. Jellison, E.R., Kim, S.K., Welsh, R.M., Cutting edge: MHC class II-restricted killing in vivo during viral infection. Journal of Immunology, 174, 2005, 614.
58. Johnston, J.B., McFadden, G., Poxvirus immunomodulatory strategies: Current perspectives. Journal of Virology, 77, 2003, 6093.
59. Karupiah, G., Buller, R.M., Van Rooijen, N., Duarte, C.J., Chen, J., Different roles for CD4 + and CD8 + T lymphocytes and macrophage subsets in the control of a generalized virus infection. Journal of Virology, 70, 1996, 8301.
60. Karupiah, G., Chen, J.H., Nathan, C.F., Mahalingam, S., MacMicking, J.D., Identification of nitric oxide synthase 2 as an innate resistance locus against ectromelia virus infection. Journal of Virology, 72, 1998, 7703.
61. Karupiah, G., Fredrickson, T.N., Holmes, K.L., Khairallah, L.H., Buller, R.M., Importance of interferons in recovery from mousepox. Journal of Virology, 67, 1993, 4214.
62. Karupiah, G., Xie, Q.W., Buller, R.M., Nathan, C., Duarte, C., MacMicking, J.D., Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science, 261, 1993, 1445.
63. Krensky, A.M., Ault, K.A., Reiss, C.S., Strominger, J.L., Burakoff, S.J., Generation of long-term human cytolytic cell lines with persistent natural killer activity. Journal of Immunology, 129, 1982, 1748.
64. Lanier, L.L., NK cell recognition. Annual Review of Immunology, 23, 2005, 225.
65. Lau, L.L., Jamieson, B.D., Somasundaram, T., Ahmed, R., Cytotoxic T-cell memory without antigen. Nature, 369, 1994, 648.
66. Lustig, S., Maik-Rachline, G., Paran, N., Melamed, S., Israely, T., Erez, N., et al. Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response. Vaccine, 27, 2009, 1691.
67. Ma, X., Xu, R.H., Roscoe, F., Whitbeck, J.C., Eisenberg, R.J., Cohen, G.H., et al. The mature virion of ectromelia virus, a pathogenic poxvirus, is capable of intrahepatic spread and can serve as a target for delayed therapy. Journal of Virology, 87, 2013, 7046.
68. Mack, T.M., Noble, J. Jr., Thomas, D.B., A prospective study of serum antibody and protection against smallpox. The American Journal of Tropical Medicine and Hygiene, 21, 1972, 214.
69. Mohamed, M.R., McFadden, G., NFkB inhibitors: Strategies from poxviruses. Cell Cycle, 8, 2009, 3125.
70. Mohamed, M.R., Rahman, M.M., Lanchbury, J.S., Shattuck, D., Neff, C., Dufford, M., et al. Proteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxviruses. Proceedings of the National Academy of Sciences of the United States of America, 106, 2009, 9045.
71. Moss, B., Poxviridae: The viruses and their replication. Fields, B.N., Knipe, D.M., Howley, P.M., (eds.) Fields virology, 1996, Raven Press, Philadelphia, 2950.
72. Mullbacher, A., Hla, R.T., Museteanu, C., Simon, M.M., Perforin is essential for control of ectromelia virus but not related poxviruses in mice. Journal of Virology, 73, 1999, 1665.
73. Mullbacher, A., Waring, P., Tha Hla, R., Tran, T., Chin, S., Stehle, T., et al. Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proceedings of the National Academy of Sciences of the United States of America, 96, 1999, 13950.
74. Muller, D., Koller, B.H., Whitton, J.L., LaPan, K.E., Brigman, K.K., Frelinger, J.A., LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice. Science, 255, 1992, 1576.
75. Oehen, S., Waldner, H., Kundig, T., Hengartner, H., Zinkernagel, R., Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. The Journal of Experimental Medicine, 176, 1992, 1273.
76. O'Neill, H.C., Blanden, R.V., Mechanisms determining innate resistance to ectromelia virus infection in C57BL mice. Infection and Immunity, 41, 1983, 1391.
77. Panchanathan, V., Chaudhri, G., Karupiah, G., Interferon function is not required for recovery from a secondary poxvirus infection. Proceedings of the National Academy of Sciences of the United States of America, 102, 2005, 12921.
78. Panchanathan, V., Chaudhri, G., Karupiah, G., Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function. Journal of Virology, 80, 2006, 6333.
79. Panchanathan, V., Chaudhri, G., Karupiah, G., Correlates of protective immunity in poxvirus infection: Where does antibody stand?. Immunology and Cell Biology, 86, 2008, 80.
80. Panchanathan, V., Chaudhri, G., Karupiah, G., Antiviral protection following immunization correlates with humoral but not cell-mediated immunity. Immunology and Cell Biology, 88, 2010, 461.
81. Pang, T., McKenzie, I.F., Blanden, R.V., Cooperation between mouse T-cell subpopulations in the cell-mediated response to a natural poxvirus pathogen. Cellular Immunology, 26, 1976, 153.
82. Paran, N., Lustig, S., Zvi, A., Erez, N., Israely, T., Melamed, S., et al. Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response. Virology Journal, 10, 2013, 229.
83. Paran, N., Suezer, Y., Lustig, S., Israely, T., Schwantes, A., Melamed, S., et al. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox. The Journal of Infectious Diseases, 199, 2009, 39.
84. Parker, A.K., Parker, S., Yokoyama, W.M., Corbett, J.A., Buller, R.M., Induction of natural killer cell responses by ectromelia virus controls infection. Journal of Virology, 81, 2007, 4070.
85. Parren, P., Burton, D.R., The antiviral activity of antibodies in vitro and in vivo. Advances in Immunology, 77, 2001, 195.
86. Payne, L.G., Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. The Journal of General Virology, 50, 1980, 89.
87. Potsch, C., Vohringer, D., Pircher, H., Distinct migration patterns of naive and effector CD8 T cells in the spleen: Correlation with CCR7 receptor expression and chemokine reactivity. European Journal of Immunology, 29, 1999, 3562.
88. Remakus, S., Rubio, D., Lev, A., Ma, X., Fang, M., Xu, R.H., et al. Memory CD8(+) T cells can outsource IFN-gamma production but not cytolytic killing for antiviral protection. Cell Host & Microbe, 13, 2013, 546.
89. Remakus, S., Rubio, D., Ma, X., Sette, A., Sigal, L.J., Memory CD8 + T cells specific for a single immunodominant or subdominant determinant induced by peptide-dendritic cell immunization protect from an acute lethal viral disease. Journal of Virology, 86, 2012, 9748.
90. Rubio, D., Xu, R.H., Remakus, S., Krouse, T.E., Truckenmiller, M.E., Thapa, R.J., et al. Crosstalk between the type 1 interferon and nuclear factor kappa B pathways confers resistance to a lethal virus infection. Cell Host & Microbe, 13, 2013, 701.
91. Ruiz-Arguello, M.B., Smith, V.P., Campanella, G.S., Baleux, F., Arenzana-Seisdedos, F., Luster, A.D., et al. An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain. Journal of Virology, 82, 2008, 917.
92. Ryan, J.C., Naper, C., Hayashi, S., Daws, M.R., Physiologic functions of activating natural killer (NK) complex-encoded receptors on NK cells. Immunological Reviews, 181, 2001, 126.
93. Sakala, I.G., Chaudhri, G., Buller, R.M., Nuara, A.A., Bai, H., Chen, N., et al. Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection. Journal of Virology, 81, 2007, 3346.
94. Samuelsson, C., Hausmann, J., Lauterbach, H., Schmidt, M., Akira, S., Wagner, H., et al. Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection. The Journal of Clinical Investigation, 118, 2008, 1776.
95. Saraiva, M., Alcami, A., CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses. Journal of Virology, 75, 2001, 226.
96. Sarkar, J.K., Mitra, A.C., Mukherjee, M.K., The minimum protective level of antibodies in smallpox. Bulletin of the World Health Organization, 52, 1975, 307.
97. Schell, K., Studies on the innate resistance of mice to infection with mousepox. I. Resistance and antibody production. The Australian Journal of Experimental Biology and Medical Science, 38, 1960, 271.
98. Seet, B.T., Johnston, J.B., Brunetti, C.R., Barrett, J.W., Everett, H., Cameron, C., et al. Poxviruses and immune evasion. Annual Review of Immunology, 21, 2003, 377.
99. Siciliano, N.A., Hersperger, A.R., Lacuanan, A.M., Xu, R.H., Sidney, J., Sette, A., et al. Impact of distinct poxvirus infections on the specificities and functionalities of CD4 + T cell responses. Journal of Virology, 88, 2014, 10078.
100. Smith, V.P., Alcami, A., Expression of secreted cytokine and chemokine inhibitors by ectromelia virus. Journal of Virology, 74, 2000, 8460.
101. Smith, V.P., Alcami, A., Inhibition of interferons by ectromelia virus. Journal of Virology, 76, 2002, 1124.
102. Smith, V.P., Bryant, N.A., Alcami, A., Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. The Journal of General Virology, 81, 2000, 1223.
103. Smith, G.L., Vanderplasschen, A., Law, M., The formation and function of extracellular enveloped vaccinia virus. The Journal of General Virology, 83, 2002, 2915.
104. Suni, M.A., Ghanekar, S.A., Houck, D.W., Maecker, H.T., Wormsley, S.B., Picker, L.J., et al. CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens. European Journal of Immunology, 31, 2001, 2512.
105. Sutherland, D.B., Ranasinghe, C., Regner, M., Phipps, S., Matthaei, K.I., Day, S.L., et al. Evaluating vaccinia virus cytokine co-expression in TLR GKO mice. Immunology and Cell Biology, 89, 2011, 706.
106. Symons, J.A., Alcami, A., Smith, G.L., Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell, 81, 1995, 551.
107. Theofilopoulos, A.N., Baccala, R., Beutler, B., Kono, D.H., Type I interferons (alpha/beta) in immunity and autoimmunity. Annual Review of Immunology, 23, 2005, 307.
108. Trapani, J.A., Jans, D.A., Jans, P.J., Smyth, M.J., Browne, K.A., Sutton, V.R., Efficient nuclear targeting of granzyme B and the nuclear consequences of apoptosis induced by granzyme B and perforin are caspase-dependent, but cell death is caspase-independent. The Journal of Biological Chemistry, 273, 1998, 27934.
109. Trapani, J.A., Smyth, M.J., Functional significance of the perforin/granzyme cell death pathway. Nature Reviews. Immunology, 2, 2002, 735.
110. Tscharke, D.C., Karupiah, G., Zhou, J., Palmore, T., Irvine, K.R., Haeryfar, S.M., et al. Identification of poxvirus CD8 + T cell determinants to enable rational design and characterization of smallpox vaccines. The Journal of Experimental Medicine, 201, 2005, 95.
111. Tsuru, S., Kitani, H., Seno, M., Abe, M., Zinnaka, Y., Nomoto, K., Mechanism of protection during the early phase of a generalized viral infection. I. Contribution of phagocytes to protection against ectromelia virus. The Journal of General Virology, 64(Pt 9), 1983, 2021.
112. Turner, G.S., Squires, E.J., Inactivated smallpox vaccine: Immunogenicity of inactivated intracellular and extracellular vaccinia virus. The Journal of General Virology, 13, 1971, 19.
113. Turner, G.S., Squires, E.J., Murray, H.G., Inactivated smallpox vaccine. A comparison of inactivation methods. The Journal of Hygiene, 68, 1970, 197.
114. Vance, R.E., Jamieson, A.M., Cado, D., Raulet, D.H., Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation. Proceedings of the National Academy of Sciences of the United States of America, 99, 2002, 868.
115. Volz, A., Langenmayer, M., Jany, S., Kalinke, U., Sutter, G., Rapid expansion of CD8 + T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara. Journal of Virology, 88, 2014, 10946.
116. Wallace, G.D., Buller, R.M., Kinetics of ectromelia virus (mousepox) transmission and clinical response in C57BL/6j, BALB/cByj and AKR/J inbred mice. Laboratory Animal Science, 35, 1985, 41.
117. Wallace, G.D., Buller, R.M., Morse, H.C. 3rd, Genetic determinants of resistance to ectromelia (mousepox) virus-induced mortality. Journal of Virology, 55, 1985, 890.
118. Wang, Y., Chaudhri, G., Jackson, R.J., Karupiah, G., IL-12p40 and IL-18 play pivotal roles in orchestrating the cell-mediated immune response to a poxvirus infection. Journal of Immunology, 183, 2009, 3324.
119. Welsh, R.M., Selin, L.K., Szomolanyi-Tsuda, E., Immunological memory to viral infections. Annual Review of Immunology, 22, 2004, 711.
120. Whitton, J.L., Oldstone, M.B., Immune response to viruses. Fields, B.N., Knipe, D.M., Howley, P.M., Griffin, D.E., (eds.) Fields' virology, 2001, Lippincott Williams & Wilkins, Philadelphia, 285.
121. Wu, J., Chen, Z.J., Innate immune sensing and signaling of cytosolic nucleic acids. Annual Review of Immunology, 32, 2014, 461.
122. Xiao, Y., Aldaz-Carroll, L., Ortiz, A.M., Whitbeck, J.C., Alexander, E., Lou, H., et al. A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost. Vaccine, 25, 2007, 1214.
123. Xie, H., Lim, Y.C., Luscinskas, F.W., Lichtman, A.H., Acquisition of selectin binding and peripheral homing properties by CD4(+) and CD8(+) T cells. The Journal of Experimental Medicine, 189, 1999, 1765.
124. Xu, R.H., Cohen, M., Tang, Y., Lazear, E., Whitbeck, J.C., Eisenberg, R.J., et al. The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination. The Journal of Experimental Medicine, 205, 2008, 981.
125. Xu, R.H., Fang, M., Klein-Szanto, A., Sigal, L.J., Memory CD8 + T cells are gatekeepers of the lymph node draining the site of viral infection. Proceedings of the National Academy of Sciences of the United States of America, 104, 2007, 10992.
126. Xu, R., Johnson, A.J., Liggitt, D., Bevan, M.J., Cellular and humoral immunity against vaccinia virus infection of mice. Journal of Immunology, 172, 2004, 6265.
127. Xu, R.H., Rubio, D., Roscoe, F., Krouse, T.E., Truckenmiller, M.E., Norbury, C.C., et al. Antibody inhibition of a viral type 1 interferon decoy receptor cures a viral disease by restoring interferon signaling in the liver. PLoS Pathogens, 8, 2012, e1002475.
128. Xu, R.H., Wong, E.B., Rubio, D., Roscoe, F., Ma, X., Nair, S., et al. Sequential activation of two pathogen-sensing pathways is required for type I interferon expression and resistance to an acute DNA virus infection. Immunity, 2015 In Press.
129. Yokoyama, W.M., Ryan, J.C., Hunter, J.J., Smith, H.R., Stark, M., Seaman, W.E., cDNA cloning of mouse NKR-P1 and genetic linkage with LY-49. Identification of a natural killer cell gene complex on mouse chromosome 6. Journal of Immunology, 147, 1991, 3229.
130. Zajac, A.J., Quinn, D.G., Cohen, P.L., Frelinger, J.A., Fas-dependent CD4 + cytotoxic T-cell-mediated pathogenesis during virus infection. Proceedings of the National Academy of Sciences of the United States of America, 93, 1996, 14730.
131. Zinkernagel, R.M., On natural and artificial vaccinations. Annual Review of Immunology, 21, 2003, 515.
132. Zinkernagel, R.M., Bachmann, M.F., Kundig, T.M., Oehen, S., Pirchet, H., Hengartner, H., On immunological memory. Annual Review of Immunology, 14, 1996, 333.
133. Zinkernagel, R.M., Hengartner, H., Protective ‘immunity' by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called 'immunological memory'. Immunological Reviews, 211, 2006, 310.
134. Zinkernagel, R.M., LaMarre, A., Ciurea, A., Hunziker, L., Ochsenbein, A.F., McCoy, K.D., et al. Neutralizing antiviral antibody responses. Advances in Immunology, 79, 2001, 1.